# FDA Inspection 847982 - Octapharma Plasma, Inc. - August 26, 2013

Source: https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/e81ba3f8-c357-4ac9-b7b3-50d0191e893f
Source feed: FDA_Inspections

> FDA Inspection 847982 for Octapharma Plasma, Inc. on August 26, 2013. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 847982
- Company Name: Octapharma Plasma, Inc.
- Inspection Date: 2013-08-26
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1151448 - 2021-08-12](https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/f1dfc4b2-862e-4a21-839c-da314e0339cb)
- [FDA Inspection 1151448 - 2021-08-12](https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/99fd92c1-84f4-4eb5-a31d-9454316622a8)
- [FDA Inspection 1063785 - 2018-08-02](https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/77523981-9218-4357-bc24-483608c45049)
- [FDA Inspection 940667 - 2015-09-04](https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/aa01e1fe-0b5f-454a-9166-943a60397356)

Company: https://www.keypedia.com/companies/octapharma-plasma-inc/3cc5f35f-e09d-484c-8486-53e2b444d75e

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d